Skip to main content
TipRanks
Go Ultimate75% OFF

SK bioscience Co.,Ltd. (302440) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

SK bioscience Co.,Ltd. has a market cap or net worth of KRW 3.08T. The enterprise value is KRW 2.77T.

Market Cap
KRW 3.08T
Enterprise Value
KRW 2.77T

Share Statistics

SK bioscience Co.,Ltd. has 78,456,550 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
78,456,550
Owned by Insiders
―
Owned by Institutions
3.07%

Financial Efficiency

SK bioscience Co.,Ltd.’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -3.75%.

Return on Equity (ROE)
-0.03
Return on Assets (ROA)
-0.02
Return on Invested Capital (ROIC)
-3.75%
Return on Capital Employed (ROCE)
-0.06
Revenue Per Employee
661.96M
Profits Per Employee
-57.09M
Employee Count
984
Asset Turnover
0.22
Inventory Turnover
3.13

Valuation Ratios

The current PE Ratio of SK bioscience Co.,Ltd. is -31.57. SK bioscience Co.,Ltd.’s PEG ratio is 0.07.

PE Ratio
-31.57
PS Ratio
4.46
PB Ratio
2.07
Price to FCF
-24.32
Price to Operating Cash Flow
-131.02
PEG Ratio
0.07

Income Statement

In the last 12 months, SK bioscience Co.,Ltd. had revenue of 651.37B and earned -56.17B in profits. Earnings per share was -718.26.

Revenue
651.37B
Gross Profit
59.49B
Operating Income
-151.33B
Pretax Income
-85.86B
Net Income
-56.17B
EBITDA
-60.31B
Earnings Per Share (EPS)
-718.26

Cash Flow

In the last 12 months, operating cash flow was -26.83B and capital expenditures -99.97B, giving a free cash flow of -126.80B billion.

Operating Cash Flow
-26.83B
Free Cash Flow
-126.80B
Free Cash Flow per Share
-1417.75

Dividends & Yields

SK bioscience Co.,Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-4.11%
Earnings Yield
-2.61%

Stock Price Statistics

Beta
0.20
52-Week Price Change
-28.02%
50-Day Moving Average
36144.00
200-Day Moving Average
39595.75
Relative Strength Index (RSI)
63.43
Average Volume (3m)
87.67K

Important Dates

SK bioscience Co.,Ltd. upcoming earnings date is Feb 10, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Feb 10, 2027
Ex-Dividend Date
―

Financial Position

SK bioscience Co.,Ltd. as a current ratio of 3.82, with Debt / Equity ratio of 26.27%

Current Ratio
3.82
Quick Ratio
3.24
Debt to Market Cap
0.12
Net Debt to EBITDA
-6.04
Interest Coverage Ratio
-16.10

Taxes

In the past 12 months, SK bioscience Co.,Ltd. has paid -29.69B in taxes.

Income Tax
-29.69B
Effective Tax Rate
0.35

Enterprise Valuation

SK bioscience Co.,Ltd. EV to EBITDA ratio is -27.08, with an EV/FCF ratio of -28.14.

EV to Sales
5.16
EV to EBITDA
-27.08
EV to Free Cash Flow
-28.14
EV to Operating Cash Flow
-132.99

Balance Sheet

SK bioscience Co.,Ltd. has KRW 832.55B in cash and marketable securities with KRW 558.63B in debt, giving a net cash position of KRW 273.92B billion.

Cash & Marketable Securities
KRW 832.55B
Total Debt
KRW 558.63B
Net Cash
KRW 273.92B
Net Cash Per Share
KRW 3,491.40
Tangible Book Value Per Share
KRW 18.49K

Margins

Gross margin is 10.95%, with operating margin of -22.70%, and net profit margin of -13.29%.

Gross Margin
10.95%
Operating Margin
-22.70%
Pretax Margin
-11.51%
Net Profit Margin
-13.29%
EBITDA Margin
-19.07%
EBIT Margin
-33.35%

Analyst Forecast

The average price target for SK bioscience Co.,Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
10.72%
EPS Growth Forecast
-1481.30%

Scores

Smart Score
―
AI Score
50